Beaula Koduri M.D.

Write a Review732-483-4501

CLOSED NOW - Opens at 9:00am

Oncologists are physicians who study, diagnose, and treat cancerous tumors. They educate patients about their illness and explain what course of treatment will take place and the amount of radiation, chemotherapy, or drugs that should be used. Oncologists develop and manage treatment programs, such as radiation therapy or chemotherapy, and will discuss with patients potential side effects or long-term effects that may occur as a result of the treatment used. They also monitor and care for patients during and after treatment. Hematology, also spelled hematology, is the branch of biology (physiology), pathology, clinical laboratory, internal medicine, and pediatrics that is concerned with the study of blood, the blood-forming organs, and blood diseases. Hematology includes the study of etiology, diagnosis, treatment, prognosis, and prevention of blood diseases. Physicians specialized in hematology are known as hematologists. Their routine work mainly includes the care and treatment of patients with hematological diseases, although some may also work at the haematology laboratory viewing blood films and bone marrow slides under the microscope, interpreting various haematological test results. In some institutions, haematologists also manage the haematology laboratory. Physicians who work in haematology laboratories, and most commonly manage them, are pathologists specialized in the diagnosis of haematological diseases, referred to as haematopathologists. Haematologists and haematopathologists generally work in conjunction to formulate a diagnosis and deliver the most appropriate therapy if needed. Haematology is a distinct subspecialty of internal medicine, separate from but overlapping with the subspecialty of medical oncology. Beaula Koduri, M.D., received her medical degree from Osmania Medical College in Hyderabad, India and completed internal medicine residencies at Pennsylvania Hospital in Philadelphia and Morristown Memorial Hospital in New Jersey. Dr. Koduri also completed a fellowship in hematology/oncology at Lankenau Hospital in Wynnewood, Pennsylvania, where she also conducted research on whether the absence of BIN-1 protein can be used as a prognostic indicator for metastatic breast cancer. Dr. Koduri is board certified in internal medicine and oncology and is a member of the American Medical Association, the American Society of Hematology, the American Society of Clinical Oncology and the Pennsylvania Medical Society.